We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+16.23%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$304M
AUM Growth
+$49.6M
Cap. Flow
+$31.6M
Cap. Flow %
10.41%
Top 10 Hldgs %
53.1%
Holding
96
New
25
Increased
23
Reduced
11
Closed
32

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$13.1M
2
CELG
Celgene Corp
CELG
+$12.7M
3
BAX icon
Baxter International
BAX
+$11.9M
4
OMED
OncoMed Pharmaceuticals, Inc.
OMED
+$5.63M
5
VTRS icon
Viatris
VTRS
+$5.53M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$14M
2
PFE icon
Pfizer
PFE
+$9.42M
3
EW icon
Edwards Lifesciences
EW
+$8.53M
4
MCK icon
McKesson
MCK
+$5.55M
5
MDT icon
Medtronic
MDT
+$5.02M

Sector Composition

Rank Sector Weight
1 Healthcare 78.26%
2 Financials 1.78%
3 Consumer Staples 0.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLV icon
1
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$36M 11.85%
+500,000
New +$35.3M
CELG
2
DELISTED
Celgene Corp
CELG
$24M 7.88%
200,000
+110,000
+122% +$12.7M
CI icon
3
Cigna
CI
$72B
$19.8M 6.5%
135,000
+95,000
+238% +$13.1M
AMGN icon
4
Amgen
AMGN
$218B
$16.2M 5.34%
100,000
+35,000
+54% +$5.5M
RARE icon
5
Ultragenyx Pharmaceutical
RARE
$2.49B
$12.9M 4.24%
115,000
+5,000
+5% +$500K
BAX icon
6
Baxter International
BAX
$14.3B
$12.4M 4.08%
+325,000
New +$11.9M
VTRS icon
7
Viatris
VTRS
$20.1B
$12.2M 4%
225,000
+115,000
+105% +$5.53M
TEVA icon
8
Teva Pharmaceuticals
TEVA
$40.3B
$9.85M 3.24%
150,000
+50,000
+50% +$3.09M
GILD icon
9
Gilead Sciences
GILD
$162B
$9.11M 3%
90,000
-10,000
-10% -$1.04M
OMED
10
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$9.02M 2.97%
400,000
+275,000
+220% +$5.63M
XLRN
11
DELISTED
Acceleron Pharma
XLRN
$7.31M 2.41%
150,000
+40,000
+36% +$1.44M
BIIB icon
12
Biogen
BIIB
$30.1B
$6.13M 2.02%
20,000
-10,000
-33% -$2.87M
AET
13
DELISTED
Aetna Inc
AET
$5.41M 1.78%
50,000
– –
MRK icon
14
Merck
MRK
$318B
$5.28M 1.74%
+104,800
New +$5.28M
ESRX
15
DELISTED
Express Scripts Holding Company
ESRX
$5.25M 1.73%
60,000
-15,000
-20% -$1.28M
ENDP
16
DELISTED
Endo International plc
ENDP
$4.59M 1.51%
75,000
+5,000
+7% +$304K
ADAP
17
DELISTED
Adaptimmune Therapeutics
ADAP
$4.26M 1.4%
353,161
+278,161
+371% +$2.72M
MDRX
18
DELISTED
Veradigm Inc. Common Stock
MDRX
$4.23M 1.39%
275,000
+15,000
+6% +$215K
GWPH
19
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$4.21M 1.39%
60,687
+20,687
+52% +$1.69M
SRPT icon
20
Sarepta Therapeutics
SRPT
$1.79B
$3.86M 1.27%
+100,000
New +$3.24M
PCRX icon
21
Pacira BioSciences
PCRX
$999M
$3.84M 1.26%
+50,000
New +$2.83M
AXDX
22
DELISTED
Accelerate Diagnostics
AXDX
$3.76M 1.24%
17,500
+2,500
+17% +$456K
CYTK icon
23
Cytokinetics
CYTK
$10.8B
$3.66M 1.2%
+350,000
New +$3.43M
GBT
24
DELISTED
Global Blood Therapeutics, Inc.
GBT
$3.56M 1.17%
110,000
+45,000
+69% +$1.95M
HTWR
25
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$3.53M 1.16%
+70,000
New +$3.29M
1
2 3 4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q4 2015 Portfolio in Review

As of Q4 2015, Iguana Healthcare Management held 96 positions worth $304M, up 20% from $254M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Iguana Healthcare Management deployed $31.6M of net new capital in Q4 2015, opening 25 new positions and adding to 23 existing holdings. Its largest new stake was Baxter International: 325,000 shares worth $12.4M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 74% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Bausch Health, an estimated $4.49M trimmed.

  • Iguana Healthcare Management's largest Q4 2015 buy was Baxter International: 325,000 shares worth $12.4M.
  • Iguana Healthcare Management added most to Cigna in Q4 2015, an estimated $13.1M increase.
  • Iguana Healthcare Management's biggest Q4 2015 reduction was Bausch Health, cutting an estimated $4.49M.
  • Iguana Healthcare Management fully exited Elevance Health in Q4 2015, selling an estimated $14M.
  • Iguana Healthcare Management's ten largest holdings make up 53% of its $304M portfolio in Q4 2015.
  • Iguana Healthcare Management opened 25 new positions and closed 32 in Q4 2015.
  • Iguana Healthcare Management's portfolio value rose 20% quarter-over-quarter to $304M.

Based on Iguana Healthcare Management's 13F filing for Q4 2015, filed 16 Feb 2016.